David Toung Analyst Performance

Senior Analyst at Argus

David Toung is a stock analyst at Argus focused in the healthcare sector, covering 27 publicly traded companies. Over the past year, David Toung has issued 21 stock ratings, including buy and hold recommendations. While full access to David Toung's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights David Toung's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
72 Last 12 Years
Buy Recommendations
81.54% 53 Buy Ratings
Companies Covered
27 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy4.6%3 ratings
Buy76.9%50 ratings
Hold18.5%12 ratings
Sell0.0%0 ratings

Out of 65 total stock ratings issued by David Toung at Argus, the majority (76.9%) have been Buy recommendations, followed by 18.5% Hold and 4.6% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NYSE
77.8% of companies on NYSE
21 companies
NASDAQ
22.2% of companies on NASDAQ
6 companies

David Toung, an analyst at Argus, currently covers 27 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Healthcare
26 companies
96.3%
Technology
1 company
3.7%

David Toung of Argus specializes in stock coverage within the Healthcare sector, with additional focus on Technology companies.

Coverage Industries

IndustryPercentage
HEALTHCARE EQUIPMENT & SUPPLIES
10 companies
37.0%
HEALTHCARE PROVIDERS & SERVICES
7 companies
25.9%
LIFE SCIENCES TOOLS & SERVICES
4 companies
14.8%
PHARMACEUTICALS
3 companies
11.1%
BIOTECHNOLOGY
2 companies
7.4%
SEMICONDUCTORS & SEMICONDUCTOR EQUIPMENT
1 company
3.7%

David Toung's Ratings History at Argus

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
11/12/2026Boost Price Target$277.63$309.00Buy
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
11/11/2026Boost Price Target$82.96$110.00Buy
Pfizer Inc. stock logo
PFE
Pfizer
11/4/2026Set Price Target$30.79$40.00
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
10/30/2026Boost Price Target$705.03$780.00Buy
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
10/22/2026Reiterated Rating$97.54$125.00Buy
Cencora, Inc. stock logo
COR
Cencora
10/20/2026Boost Price Target$340.07$380.00Buy
Boston Scientific Corporation stock logo
BSX
Boston Scientific
7/31/2026Downgrade$45.92Hold
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
7/29/2026Set Price Target$268.48$300.00
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
7/20/2026Boost Price Target$371.80$470.00Buy
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
6/18/2026Upgrade$17.20$25.00Buy
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
4/30/2026Lower Price Target$692.22$560.00
Boston Scientific Corporation stock logo
BSX
Boston Scientific
4/27/2026Lower Price Target$43.01$95.00Buy
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
4/22/2026Upgrade$346.26$400.00Buy
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
4/15/2026Downgrade$11.06Hold
Medtronic PLC stock logo
MDT
Medtronic
4/6/2026Lower Price Target$86.62$115.00Buy
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
3/23/2026Lower Price Target$156.29$180.00Buy
Pfizer Inc. stock logo
PFE
Pfizer
3/2/2026Upgrade$27.61$35.00Buy
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
2/6/2026Boost Price Target$501.59$560.00Buy
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
1/23/2026Boost Price Target$220.29$240.00
Hologic, Inc. stock logo
HOLX
Hologic
1/12/2026Downgrade$74.87Hold
Bio-Techne Corp stock logo
TECH
Bio-Techne
11/20/2025Boost Price Target$57.81$68.00Buy
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
10/29/2025Boost Price Target$570.59$610.00Buy
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
10/15/2025Set Price Target$190.63$210.00
Hologic, Inc. stock logo
HOLX
Hologic
9/19/2025Boost Price Target$68.27$90.00Buy
Medtronic PLC stock logo
MDT
Medtronic
8/26/2025Boost Price Target$92.05$115.00Buy
Elevance Health, Inc. stock logo
ELV
Elevance Health
7/21/2025Reiterated Rating$276.87Hold
GlobalFoundries Inc. stock logo
GFS
GlobalFoundries
7/1/2025Initiated Coverage$38.20$52.00Buy
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
4/29/2025Lower Price Target$426.24$470.00Buy
Elevance Health, Inc. stock logo
ELV
Elevance Health
4/25/2025Set Price Target$413.41$465.00
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
4/21/2025Downgrade$456.10Hold
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
3/31/2025Upgrade$21.69Buy
Elevance Health, Inc. stock logo
ELV
Elevance Health
3/17/2025Upgrade$421.72$450.00Buy
Hologic, Inc. stock logo
HOLX
Hologic
3/3/2025Downgrade$63.38Hold
Stryker Corporation stock logo
SYK
Stryker
2/3/2025Set Price Target$382.59$450.00
Elevance Health, Inc. stock logo
ELV
Elevance Health
1/29/2025Reiterated Rating$405.67$405.40Hold
Abbott Laboratories stock logo
ABT
Abbott Laboratories
1/28/2025Upgrade$128.75Strong-Buy
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
1/24/2025Upgrade$152.91Strong-Buy